Anti-SLUR2/ SLURP2/ SLURP-2 monoclonal antibody

Anti-SLUR2/ SLURP2/ SLURP-2 antibody for FACS & in-vivo assay

Target products collectionGo to SLURP2/SLURP2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2571-Ab-1/ GM-Tg-hg-MP2571-Ab-2Anti-Human SLURP2 monoclonal antibodyHuman
GM-Tg-rg-MP2571-Ab-1/ GM-Tg-rg-MP2571-Ab-2Anti-Rat SLURP2 monoclonal antibodyRat
GM-Tg-mg-MP2571-Ab-1/ GM-Tg-mg-MP2571-Ab-2Anti-Mouse SLURP2 monoclonal antibodyMouse
GM-Tg-cynog-MP2571-Ab-1/ GM-Tg-cynog-MP2571-Ab-2Anti-Cynomolgus/ Rhesus macaque SLURP2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2571-Ab-1/ GM-Tg-felg-MP2571-Ab-2Anti-Feline SLURP2 monoclonal antibodyFeline
GM-Tg-cang-MP2571-Ab-1/ GM-Tg-cang-MP2571-Ab-2Anti-Canine SLURP2 monoclonal antibodyCanine
GM-Tg-bovg-MP2571-Ab-1/ GM-Tg-bovg-MP2571-Ab-2Anti-Bovine SLURP2 monoclonal antibodyBovine
GM-Tg-equg-MP2571-Ab-1/ GM-Tg-equg-MP2571-Ab-2Anti-Equine SLURP2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg

Product Description

Catalog No.GM-Tg-hg-MP2571-Ab-1/ GM-Tg-hg-MP2571-Ab-2; GM-Tg-rg-MP2571-Ab-1/ GM-Tg-rg-MP2571-Ab-2;
GM-Tg-mg-MP2571-Ab-1/ GM-Tg-mg-MP2571-Ab-2; GM-Tg-cynog-MP2571-Ab-1/ GM-Tg-cynog-MP2571-Ab-2;
GM-Tg-felg-MP2571-Ab-1/ GM-Tg-felg-MP2571-Ab-2; GM-Tg-cang-MP2571-Ab-1/ GM-Tg-cang-MP2571-Ab-2;
GM-Tg-bovg-MP2571-Ab-1/ GM-Tg-bovg-MP2571-Ab-2; GM-Tg-equg-MP2571-Ab-1/ GM-Tg-equg-MP2571-Ab-2
Products NameAnti-SLURP2 monoclonal antibody
Target NameSLURP2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
Products descriptionPre-made anti-SLURP2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


    Data / case study

    Click to get more Data / Case study about the product.

    Associated products

    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SLUR2/ SLURP2/ SLURP-2 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP002890human SLURP2 Lentivirus particle
    ORF Viral VectorpGMLP002890human SLURP2 Lentivirus plasmid

    Target information

    Target IDGM-MP2571
    Target NameSLURP2
    Gene ID432355,69462,315074,100428508,100683842,109496272
    Gene Symbol and Synonyms2300005B03Rik,LYNX1,RGD1308195,SLURP-2,SLURP2
    Uniprot AccessionP0DP57
    Uniprot Entry NameSLUR2_HUMAN
    Protein Sub-locationTransmembrane Protein
    Gene EnsemblENSG00000283992
    Target ClassificationN/A

    The target: SLURP2, gene name: SLURP2, also named as SLURP-2. This gene encodes a novel, secreted member of the Ly6/uPAR (LU) superfamily of proteins containing the unique three-finger LU domain. This gene is mainly expressed in epithelial cells, including skin and keratinocytes, and is up-regulated in psoriatic skin lesions, suggesting its involvement in the pathophysiology of psoriasis. Alternatively spliced transcript variants have been found for this gene. Read-through transcription from the neighboring upstream gene (LYNX1) generates naturally-occurring transcripts (LYNX1-SLURP2) that encode a fusion protein comprised of sequence sharing identity with each individual gene product. [provided by RefSeq, Sep 2017].

    About Gmab


    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.